It's official: In 15 months, NASA will send a space shuttle to service the aging Hubble Space Telescope. Plans to return to Hubble were put on hold 4 years ago after Columbia disintegrated. NASA chief Michael Griffin pledged last year to reverse his predecessor's decision to let Hubble die, but the space agency waited until Atlantis lifted off from its Florida launch pad last week to put the 10 September 2008 servicing flight on the busy shuttle schedule.
If the maintenance mission-its fifth-is successful, Hubble will sport two new instruments. The Cosmic Origins Spectrograph and Wide Field Camera 3 will, respectively, measure the structure and composition of matter and examine the universe in multiple wavelengths. By replacing gyroscopes and filling the fuel tank, the mission is also expected to extend the life of the telescope, first launched in 1990, to 2013. That's also when NASA intends to launch its James Webb Space Telescope, Hubble's follow-on.
-ANDREW LAWLER

Peer Review Peered At, Reviewed
Two new panels will try to figure out how to tweak the vaunted peer-review process at the National Institutes of Health (NIH) to cope with soaring numbers of applications and other pressures on the agency.
NIH has created two working groups-one external, one internal-to examine the "content, criteria, and culture of peer review" in light of flat budgets, a rising number of grant applications, shrinking success rates, and a dearth of experienced reviewers (Science, 20 April, p. 358) . The external committee is co-chaired by cell biologist Keith Yamamoto of the University of California, San Francisco, a member of the last review panel 8 years ago. Yamamoto expects the new panel to probe the current emphasis on preliminary results and weigh the proper balance between the bona fides of the investigator and the value of the project itself. The internal group, co-chaired by Jeremy Berg, director of the National Institute of General Medical Sciences, will examine the same issues. Both panels are to gather input and report back in December.
Meanwhile, a House spending panel last week voted to add $750 million next year to the agency's current $29 billion budget, a 2.6% raise that lags biomedical inflation. The increase drops to 1.9% if $200 million tagged for the global AIDS fund is removed.
-JOCELYN KAISER AND ELIOT MARSHALL
SCIENCESCOPE
Medical and veterinary science are like siblings who have grown apart. But now, there's a flurry of efforts to reunite them. Proponents of this idea, called "one medicine" or "one health," say that breaking down the walls between the two fields will help fight diseases that jump from animals to humans, such as SARS and avian influenza, and advance both human and animal health.
In April, the American Veterinary Medical Association (AVMA) decided to establish a 12-member task force to recommend ways in which vets can collaborate with colleagues in human medicine. In late June, the house of delegates of the American Medical Association (AMA) will vote on a resolution in support of strengthened ties between schools of medicine and veterinary science, increased collaboration in surveillance and the development of diagnostics, drugs, and vaccines across species barriers, and a "dialogue" with AVMA. The theme is also on the program at infectious-disease meetings in Europe and the United States this year.
Although still closely connected in the 19th century, human and animal medicine became increasingly disconnected in the 20th. Recent health emergencies have occasionally driven them back into each other's arms. The global outbreak of the H5N1 avian influenza strain, for instance, has led to closer ties between the human and animal health agencies at the global and country levels.
But such collaborations are the exception when they should be the norm, especially now, with dangerous new zoonoses popping up, says Laura Kahn, an internist at Princeton University. During the 1999 West Nile outbreak in the United States, vets saw birds dying while doctors noticed an uptick in patients with neurological symptoms, but it took a while before someone made the connection. Concrete plans still need to be fleshed out, Kahn says, and obstacles abound: For instance, educational collaborations could be tough in the United States, where there are only 28 vet schools, often in rural areas, versus more than 140, mostly urban-based, schools of medicine.
The benefits of collaboration could go beyond zoonoses, says Jakob Zinsstag of the Swiss Tropical Institute in Basel. For instance, in Chad, Zinsstag has helped introduce joint vaccination campaigns for livestock and humans, which has helped raise vaccination rates of hard-to-reach nomadic populations. In the United Kingdom, the Comparative Clinical Science Foundation has announced plans to fund crossspecies studies in areas as diverse as cancer, aging, and genetic disorders-which will yield different insights than the use of animals as models for human disease, Kahn says.
The term "one medicine" was coined in 1960s by Calvin Schwabe, a veterinary scientist and epidemiologist at the University of California, Davis, who died last year. The push to put his ideas into practice originates from a fairly small number of people. Kahn, who became a convert from studying emerging diseases and bioterrorism, got the ball rolling with an article in Emerging Infectious Diseases last year. She also wrote a "vision statement"-together with Florida veterinarian Bruce Kaplan and former government virologist and biotech executive Thomas Monath, now at the investment firm Kleiner Perkins Caufield & Byers in Menlo Park, California-supported by dozens of prominent researchers. They found an enthusiastic champion in AVMA President Roger Mahr.
In a way, the movement is also a struggle by veterinarians for a place at the table in public health, says Joan Hendricks, dean of the University of Pennsylvania's vet school. "We have been knocking politely at the door for a while," she says, but human medicine has been slow to respond. But if the AMA resolution gets passed next week, she adds, "it would be a phenomenal support." 
